Who Paid My Doc
Max Respiratory Panel COVID/FLU/RSV
Research payments
$1,589,348
Through program year 2023, $1,589,348 in research payments was reported against Max Respiratory Panel COVID/FLU/RSV, across 22 payments, paid by Becton, Dickinson and Company.
- Paid by
- Becton, Dickinson and Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $297 | 1 |
| 2022 | Research | $88,258 | 3 |
| 2021 | Research | $1,500,793 | 18 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Monzer Yazji Edinburg, TX Named on 3 payments
- Thomas Davis Indianapolis, IN Named on 3 payments
- Christopher Oldfield Midway, GA Named on 3 payments
- Bernard Garcia Fort Lauderdale, FL Named on 2 payments
- Jeffrey Harris Greenville, SC Named on 2 payments
- Dany Quan Phoenix, AZ Named on 1 payment
- Marc Mickiewicz Nashville, TN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.